Stomatitis And Everolimus: A Review Of Current Literature On 8,201 Patients.
Claudia ArenaGiuseppe TroianoKhrystyna ZhurakivskaRiccardo NociniLorenzo Lo MuzioPublished in: OncoTargets and therapy (2019)
Results of the analysis showed that the incidence of stomatitis of grade 1 or 2 is higher than grade 3 or 4. However, it must be taken into account that it is not possible to say if side effects are entirely due to everolimus therapy or combinations with other drugs.